SONOMA PHARMACEUTICALS, INC. (SNOA)

1.32USD +0.38% (+0.00)

Over 6M: -47.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

1 1.5 2 2.5
Mar Apr May Jun Jul Aug Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '26 — Operating Income: -337K Q2 '26 — Net Income: -534K Q3 '26 — Operating Income: -678K Q3 '26 — Net Income: -819K Q4 '26 — Operating Income: -351K Q4 '26 — Net Income: -581K Q1 '27 — Operating Income: -40K Q1 '27 — Net Income: -330K -800K -600K -400K -200K 0
Q2 '26 Q3 '26 Q4 '26 Q1 '27
Operating Income Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
SBC / sales 1.2%
Adj. EBITDA margin -4.6%
OE margin -13.3%
Oper. margin -6.4%
ROIC -88.4%
Asset turnover 1.2×
Capex / sales 0.4%
Accruals 1.7%
Gross margin 38.9%
EBITDA margin -5.8%
FCF margin -12.1%
OCF margin -11.7%
Profit margin -10.3%
ROA -12.5%
ROCE -11.1%
ROE -34.3%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 0.04×
EV/OE -0.3×
EV/GP 0.1×
P/B 0.94×
P/C 1.2×
FCF yield -42.7%
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —
Shareholder yield —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.1
Gross margin stability across years 2.4 pp
RPO / sales 0.013×
Cash-flow margin stability 14.2 pp
Revenue growth in the worst year on record -32.2%
Prepaid revenue growth -61.4%
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 6.0
Current ratio 3.1×
Interest cover -234.3×
Debt / Eq 0.0×
Debt payback 0.0 yr
Net debt / Eq 0.0×
Quick ratio 2.3×
Cash runway 2.0 yr
Equity / Assets 36.4%
F-score 2.2 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.6
Most recent margin move 10.2
Operating margin trend 8.6
Sales CAGR 4Y +11.5%
Sales/sh Y/Y +8.3%
Gross profit Y/Y +35.7%
Sales Q/Q +59.6%
Shares change +35.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.